Combined antidepressant treatment: a risk factor for switching in bipolar patients
Gabbay, V.; O'Dowd, M.Alice.; Asnis, G.M.
Journal of Clinical Psychiatry 63(4): 367; Author Reply 367-8
2002
ISSN/ISBN: 0160-6689 PMID: 12000212 Document Number: 541196
Document emailed within 1 workday
Related Documents
Dudek, D.; Siwek, M.; Borowiecka-Kluza, J. 2008: The analysis of bipolar spectrum features in drug resistant unipolar depression patients as compared to depressive patients who responded to standard antidepressant treatment. a pilot study Psychiatria Polska 42(2): 283-294Truman, C.J.; Goldberg, J.F.; Ghaemi, S.Nassir.; Baldassano, C.F.; Wisniewski, S.R.; Dennehy, E.B.; Thase, M.E.; Sachs, G.S. 2007: Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Journal of Clinical Psychiatry 68(10): 1472-1479
Ribeiro, C.M.F.; Gurgel, W.S.; Luna, J.R.G.; Matos, K.J.N.; Souza, F.G.M. 2013: Is bipolar disorder a risk factor for HIV infection? Journal of Affective Disorders 146(1): 66-70
Ostacher, M.J. 2006: The evidence for antidepressant use in bipolar depression Journal of Clinical Psychiatry 67(Suppl 11): 18-21
Labbate, L.A.; Croft, H.A.; Oleshansky, M.A. 2003: Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation Journal of Clinical Psychiatry 64(Suppl 10): 11-19
Sabin, C.; Pasi, J.; Phillips, A.; Elford, J.; Janossy, G.; Lee, C. 1994: CD4+ counts before and after switching to monoclonal high-purity factor VIIi concentrate in HIV-infected haemophilic patients Thrombosis and Haemostasis 72(2): 214-217
Kabanov, A.N.; Suvorov, A.M.; Krasnoshchekiĭ, V.E. 1989: Evaluation of the results of combined treatment of patients with duodenal ulcer using factor analysis Klinicheskaia Khirurgiia 8: 57-59
Tanaka, T.; Inoue, T.; Suzuki, K.; Kitaichi, Y.; Masui, T.; Denda, K.; Koyama, T. 2007: Clinical relevance of antidepressant-induced activation syndrome: from a perspective of bipolar spectrum disorder Seishin Shinkeigaku Zasshi 109(8): 730-742
Diaz, A.; Fouilloux, C.; Ortiz, S. 2002: Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients Proceedings of the Western Pharmacology Society 45: 154-155
Oquendo, M.A.; Mann, J.J. 2001: Identifying and managing suicide risk in bipolar patients Journal of Clinical Psychiatry 62(Suppl 25): 31-34
Newcomer, J.W. 2006: Medical risk in patients with bipolar disorder and schizophrenia Journal of Clinical Psychiatry 67(Suppl 9): 25-30; Discussion: 36-42
Rasić, S.; Kulenović, I.; Uncanin, S. 2005: Parathormone as a cardiovascular risk factor in uraemic patients on haemodialysis treatment Medicinski Arhiv 59(4): 231-234
Yaghy, M.; Murin, J.; Pernicky, M.; Pekarovicova, Z.; Mikes, P. 2008: Antithrombotic treatment in patients with atrial fibrillation as a risk factor of stroke Bratislavske Lekarske Listy 109(3): 133-140
Descotes, J.; Lyonnet, D.; Barral, X.; Heynen, Y.G.; Brudon, J.R.; Gille, D. 1984: Aneurysms of the abdominal aorta in high risk patients. Combined treatment with surgery and radiology. Apropos of 9 cases Chirurgie; Memoires de l'Academie de Chirurgie 110(5): 552-556
Gribova, O.V.; Musabaeva, L.I.; Choĭnzonov, E.L.; Mukhamedov, M.R. 2012: The clinical course of thyroid cancer following its combined treatment with the use of fast-neutron therapy in the patients at the high risk of relapses Vestnik Otorinolaringologii 5: 91-92
Huff, T.F.; Uede, T.; Iwata, M.; Ishizaka, K. 1983: Modulation of the biologic activities of IgE-binding factors. III. Switching of a T cell hybrid clone from the formation of IgE-suppressive factor to the formation of IgE-potentiating factor Journal of Immunology 131(3): 1090-1095
Caroli, F.; Baldacci-Epinette, C.; Ribeyre, P. 1993: Antidepressant treatment of schizophrenic patients L'Encephale 19(Special Issue 2): 393-396
Yeo, T.Cheng.; Chan, Y.Huak.; Low, L.Ping.; Venketasubramanian, N.; Lim, S.Chi.; Tay, J.Chin.; Tan, R.San.; Eng, P.; Lingamanaicker, J.; Lingamanaicker, J.; Kit Ang, P.; Cumaraswamy, S.; Chan, B.; Chan, N.Fong.; Chang, H.Meng.; Li Hsian Chen, C.; Cherian, T.; Chia, K.Hoong.; Chong, P.Ngok.; Chua, S.Meng.; Chua, P.Kuan.; Da Costa, M.L.A.; De Silva, D.Anne.; Deb, B.; Doshi, M.; Eng, P.; Goh, K.Hock.; Hee Ho, K.; Gan, R.; Kurugulasigamoney, G.; Chin Kek, P.; Siam Soon Koh, P.; Thong Kiang Koh, A.; Koo, S.Long.; Koo, C.Choong.; Lee, C.Sham.; Lee, T.Yin.; Liew, S.; Liew, A.Kiong.; Lim, I.Haan 2008: Risk factor profile and treatment patterns of patients with atherothrombosis in Singapore: insight from the REACH Registry Annals of the Academy of Medicine Singapore 37(5): 365-371
Billon, S.; Escoffre-Barbe, M.; Mercier, B.; Abgrall, J.F.; Ferec, C. 1999: Fibrinogen is not an additional risk factor of thromboembolic disease in factor V Leiden patients Thrombosis and Haemostasis 81(4): 659-660
Girolami, A.; de Marco, L.; Fabris, F.; Casonato, A. 1977: Platelet adhesiveness and aggregation in combined factor V and factor VIIi deficiency and in combined factor VIi and factor VIIi deficiency Folia Haematologica 104(5): 663-669